Our Vision
Altis CRO will always conduct high-quality clinical research, profitably if possible, at a loss if necessary, but always with the highest standards of excellence
Altis CRO was founded by Dr. E. Mehmet Yusuf.
Our sister company, AlfaBeta CRO, the first biostatistics firm in Turkey, was established.
During a period when local companies’ market share declined due to globalization, Altis CRO leveraged its experience and unique perspective to expand its service offerings.
In our 24th year, we continue to grow and provide services in 17 cities.
Altis is a clinical research organization that has been providing high-quality services, guidance, and comprehensive solutions in regulatory affairs for the pharmaceutical and biomedical industries since 2001.
Our expertise covers a broad spectrum of areas, including Phase 1, Phase 2, Phase 3, and Phase 4 clinical trials, observational studies, regulatory affairs, and clinical research training.
Altis CRO operates as a Contract Research Organization (CRO) in compliance with the Good Clinical Practice (GCP) Guidelines and relevant regulations governing clinical research. It has been officially approved by the Turkish Medicines and Medical Devices Agency (TMMDA).
Altis CRO will always conduct high-quality clinical research, profitably if possible, at a loss if necessary, but always with the highest standards of excellence
To adhere to ethical principles, provide services at international standards to maximize customer satisfaction, closely follow and incorporate the latest advancements in clinical research, respect the time and rights of our clients, prioritize the development of our employees with the awareness that they are our greatest asset, and fulfill our responsibilities to humanity, science, and universal values.
Altis CRO is one of Turkey's leading Contract Research Organizations (CROs), providing high-quality services, expert guidance, and comprehensive solutions in clinical research for the pharmaceutical and biomedical industries for over 20 years. With a team of highly skilled professionals equipped with industry knowledge and technical expertise, Altis CRO is committed to meeting the specific needs of its clients. Altis CRO was founded in 2001 by Dr. Emin Mehmet Yusuf and initially operated in the clinical research sector with only two doctors, an accountant, and an assistant. By 2010, the company expanded its services with the establishment of AlfaBeta CRO, Turkey’s first biostatistics firm. By 2015, during a period when local companies' market share was declining due to globalization, Altis CRO leveraged its experience and unique perspective to diversify its clinical research services. In 2021, Altis CRO celebrated its 20th anniversary, continuing to expand its operations with more than 130 employees across 17 cities in Turkey. Over the past two decades, the company has reached and supported tens of thousands of patients. Our mission is to provide ethical, internationally standardized services to maximize customer satisfaction, stay up to date with the latest advancements in clinical research and integrate them into our operations, respect our clients' time and rights while maintaining the highest standards of integrity, invest in the development of our employees, recognizing them as our greatest asset, and fulfill our responsibilities to humanity, science, and universal values through a commitment to excellence.
E. Mehmet Yusuf earned his Doctor of Medicine (MD) degree from Istanbul Faculty of Medicine. He later completed a Master of Science (MS) in Biomedical Engineering at Boğaziçi University and obtained a PhD in Biostatistics from Cerrahpaşa University. With over 30 years of experience in various fields, including government healthcare services, hospital and occupational medicine, international pharmaceutical industry, brand and patent consultancy, and clinical research management and quality systems, E. Mehmet Yusuf is also actively engaged in higher education. He teaches graduate courses in clinical research at Boğaziçi University and serves as the Academic Course Coordinator. Additionally, he is one of the founding members of SAKDER.
Altis has been a clinical research company providing high-quality services, guidance, and comprehensive solutions in regulatory affairs for the pharmaceutical and biomedical industries since 2001.
Our expertise covers a wide range of areas, including Phase 1 - Phase 4 clinical trials, observational studies, regulatory affairs, and clinical research training.
Altis CRO serves its stakeholders with more than 130 personnel in 17 cities across our country.
Cities
Personnel